OZZZER AI NEWS · Unite.AI

Isomorphic Labs Raises $5B Series C to Advance AI Drug Design

17 Nov 2026

Isomorphic Labs Raises $5B Series C to Advance AI Drug Design

Isomorphic Labs announced on November 17, 2026 that it had raised $5 billion in Series C funding co-led by Greenoaks and Sequoia Capital, giving the AI drug-discovery company new capital to expand its design engine and move therapeutic candidates toward clinical trials.

Join free to read this story

Join for OZZZER previews and reviewed analysis. The full publisher article may require a separate subscription.

Join free to open original ↗